Skip to main content

Table 3 Serologies and markers

From: Microvascular abnormalities between anti-TIF1-γ-associated dermatomyositis with and without malignancy

Variable

N

TIF

positive

DM

(N = 19)

Inflammatory markers

  

CRP (mg/L)

18

4.0 (2.9, 10.2)

ESR (mm/1H)

19

10.0 (5.0, 24.5)

Serologies

  

ANA+

18

15 (83%)

RF+

13

2 (15%)

CCP+

13

1 (8%)

dsDNA+

18

1 (6%)

ENA panel

  

SSA/RO+

18

4 (22%)

SSB/La+

18

1 (6%)

Sm ab+

18

0 (0%)

RNP+

18

1 (6%)

SCL70+

16

3 (19%)

centromere+

16

0 (0%)

Myomarker panel 3

  

JO-1+

19

0 (0%)

MI-2+

19

0 (0%)

PL-7+

18

0 (0%)

PL-12+

19

0 (0%)

EJ+

19

0 (0%)

OJ+

19

2 (11%)

SRP+

18

1 (6%)

MDA-5+

19

0 (0%)

TIF-1 Gamma+

19

19 (100%)

Ku+

14

0 (0%)

anti-pm/scl+

17

1 (6%)

U1RNP+

14

2 (14%)

U2 SN RNP+

8

0 (0%)

Fibrillarin U3+

10

0 (0%)

SSA-52D+

11

4 (36%)

CMP

  

Aldolase (u/L)

17

4.9 (3.8, 5.5)

CK (u/L)

19

93.0 (51.0, 153.5)

  1. The sample median (Q1, Q3) is given for continuous variables, while categorical and ordinal variables are reported as frequency (percentage)